Literature DB >> 25704793

[Consensus document for the detection and management of Chagas disease in primary health care in a non-endemic areas].

Carme Roca Saumell1, Antoni Soriano-Arandes2, Lluís Solsona Díaz3, Joaquim Gascón Brustenga4.   

Abstract

Chagas disease is caused by the protozoan Trypanosoma cruzi. Although it is commonly transmitted by an insect vector in continental Latin-America, in recent decades, due migration, has been diagnosed in other countries such Spain, the European country with a largest immigrant population of Latin American. For a long time, the patient remains asymptomatic, but some years after this stage, the symptoms can be serious (dilated cardiomyopathy, megacolon, megaesophagus). In addition, detection in pregnant women has a high priority because of the route of vertical transmission. Several specific guidelines about Chagas disease has been developed on the Banks of blood, maternal hospitals, HIV co-infection, organ transplant. But due to the detection of lack of information to primary care professionals, we consider to will be useful this document written and agreed to by family phisicians, pediatricians and specialists in International Health.
Copyright © 2014 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Atención primaria de salud; Chagas disease; Enfermedad de Chagas; Primary health care; Trypanosoma cruzi

Mesh:

Year:  2015        PMID: 25704793     DOI: 10.1016/j.aprim.2015.01.002

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  8 in total

1.  Population movements, borders, and Chagas disease.

Authors:  Andrea Avaria; Laia Ventura-Garcia; Mariana Sanmartino; Carlos Van der Laat
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-07-08       Impact factor: 2.747

2.  Detection and Quantification of Viable and Nonviable Trypanosoma cruzi Parasites by a Propidium Monoazide Real-Time Polymerase Chain Reaction Assay.

Authors:  Beatriz Cancino-Faure; Roser Fisa; M Magdalena Alcover; Teresa Jimenez-Marco; Cristina Riera
Journal:  Am J Trop Med Hyg       Date:  2016-05-02       Impact factor: 2.345

3.  The role of the first level of health care in the approach to Chagas disease in a non-endemic country.

Authors:  Laura Iglesias-Rus; María Romay-Barja; Teresa Boquete; Agustín Benito; Teresa Blasco-Hernández
Journal:  PLoS Negl Trop Dis       Date:  2019-12-16

Review 4.  Roadblocks in Chagas disease care in endemic and nonendemic countries: Argentina, Colombia, Spain, and the United States. The NET-Heart project.

Authors:  Andrés F Miranda-Arboleda; Ezequiel José Zaidel; Rachel Marcus; María Jesús Pinazo; Luis Eduardo Echeverría; Clara Saldarriaga; Álvaro Sosa Liprandi; Adrián Baranchuk
Journal:  PLoS Negl Trop Dis       Date:  2021-12-30

Review 5.  Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: Part 1 (screening).

Authors:  Esmeralda Núñez Cuadros; Joan Calzada-Hernández; Daniel Clemente; Sara Guillén Martín; Laura Fernández Silveira; María José Lirola-Cruz; Alfredo Tagarro; Marisol Camacho Lovillo; Rosa María Alcobendas Rueda; Agustín López López; Miren Satrustegi Aritziturri; Cristina Calvo
Journal:  Eur J Pediatr       Date:  2022-03-08       Impact factor: 3.860

Review 6.  Treatment of Chagas Disease in the United States.

Authors:  Sheba Meymandi; Salvador Hernandez; Sandy Park; Daniel R Sanchez; Colin Forsyth
Journal:  Curr Treat Options Infect Dis       Date:  2018-06-26

7.  Phospho-proteomic analysis of primary human colon epithelial cells during the early Trypanosoma cruzi infection phase.

Authors:  Shankar Suman; Girish Rachakonda; Sammed N Mandape; Shruti S Sakhare; Fernando Villalta; Siddharth Pratap; Maria F Lima; Pius N Nde
Journal:  PLoS Negl Trop Dis       Date:  2018-09-17

8.  Mapping health behaviour related to Chagas diagnosis in a non-endemic country: Application of Andersen's Behavioural Model.

Authors:  Laura Iglesias-Rus; María Romay-Barja; Teresa Boquete; Agustín Benito; Briggitte Jordan; Teresa Blasco-Hernández
Journal:  PLoS One       Date:  2022-01-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.